160 related articles for article (PubMed ID: 9601580)
1. Clofilium in the isolated perfused rabbit heart: a new model to study proarrhythmia induced by class III antiarrhythmic drugs.
Johna R; Mertens H; Haverkamp W; Eckardt L; Niederbröker T; Borggrefe M; Breithardt G
Basic Res Cardiol; 1998 Apr; 93(2):127-35. PubMed ID: 9601580
[TBL] [Abstract][Full Text] [Related]
2. Beat-by-beat QT interval variability, but not QT prolongation per se, predicts drug-induced torsades de pointes in the anaesthetised methoxamine-sensitized rabbit.
Jacobson I; Carlsson L; Duker G
J Pharmacol Toxicol Methods; 2011; 63(1):40-6. PubMed ID: 20451633
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiologic characterization of the antipsychotic drug sertindole in a rabbit heart model of torsade de pointes: low torsadogenic potential despite QT prolongation.
Eckardt L; Breithardt G; Haverkamp W
J Pharmacol Exp Ther; 2002 Jan; 300(1):64-71. PubMed ID: 11752098
[TBL] [Abstract][Full Text] [Related]
4. QTU-prolongation and torsades de pointes induced by putative class III antiarrhythmic agents in the rabbit: etiology and interventions.
Carlsson L; Almgren O; Duker G
J Cardiovasc Pharmacol; 1990 Aug; 16(2):276-85. PubMed ID: 1697384
[TBL] [Abstract][Full Text] [Related]
5. Drug-related torsades de pointes in the isolated rabbit heart: comparison of clofilium, d,l-sotalol, and erythromycin.
Eckardt L; Haverkamp W; Mertens H; Johna R; Clague JR; Borggrefe M; Breithardt G
J Cardiovasc Pharmacol; 1998 Sep; 32(3):425-34. PubMed ID: 9733356
[TBL] [Abstract][Full Text] [Related]
6. Effects of class III antiarrhythmic agents in an in vitro rabbit model of spontaneous torsades de pointe.
D'Alonzo AJ; Zhu JL; Darbenzio RB
Eur J Pharmacol; 1999 Mar; 369(1):57-64. PubMed ID: 10204682
[TBL] [Abstract][Full Text] [Related]
7. Comparative assessment of ibutilide, D-sotalol, clofilium, E-4031, and UK-68,798 in a rabbit model of proarrhythmia.
Buchanan LV; Kabell G; Brunden MN; Gibson JK
J Cardiovasc Pharmacol; 1993 Oct; 22(4):540-9. PubMed ID: 7505355
[TBL] [Abstract][Full Text] [Related]
8. Antiarrhythmic effects of potassium channel openers in rhythm abnormalities related to delayed repolarization.
Carlsson L; Abrahamsson C; Drews L; Duker G
Circulation; 1992 Apr; 85(4):1491-500. PubMed ID: 1555289
[TBL] [Abstract][Full Text] [Related]
9. Optical mapping of drug-induced polymorphic arrhythmias and torsade de pointes in the isolated rabbit heart.
Asano Y; Davidenko JM; Baxter WT; Gray RA; Jalife J
J Am Coll Cardiol; 1997 Mar; 29(4):831-42. PubMed ID: 9091531
[TBL] [Abstract][Full Text] [Related]
10. Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
Milberg P; Eckardt L; Bruns HJ; Biertz J; Ramtin S; Reinsch N; Fleischer D; Kirchhof P; Fabritz L; Breithardt G; Haverkamp W
J Pharmacol Exp Ther; 2002 Oct; 303(1):218-25. PubMed ID: 12235254
[TBL] [Abstract][Full Text] [Related]
11. Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic.
Hondeghem LM; Carlsson L; Duker G
Circulation; 2001 Apr; 103(15):2004-13. PubMed ID: 11306531
[TBL] [Abstract][Full Text] [Related]
12. K201, a multi-channel blocker, inhibits clofilium-induced torsades de pointes and attenuates an increase in repolarization.
Hasumi H; Matsuda R; Shimamoto K; Hata Y; Kaneko N
Eur J Pharmacol; 2007 Jan; 555(1):54-60. PubMed ID: 17112502
[TBL] [Abstract][Full Text] [Related]
13. Assessment of efficacy of proarrhythmia biomarkers in isolated rabbit hearts with attenuated repolarization reserve.
Orosz S; Sarusi A; Csík N; Papp JG; Varró A; Farkas S; Forster T; Farkas AS; Farkas A
J Cardiovasc Pharmacol; 2014 Sep; 64(3):266-76. PubMed ID: 24887684
[TBL] [Abstract][Full Text] [Related]
14. Assessment of drug-induced proarrhythmia: The importance of study design in the rabbit left ventricular wedge model.
Lu HR; Gallacher DJ; Yan GX
J Pharmacol Toxicol Methods; 2016; 81():151-60. PubMed ID: 27374776
[TBL] [Abstract][Full Text] [Related]
15. Proarrhythmia as a class effect of quinolones: increased dispersion of repolarization and triangulation of action potential predict torsades de pointes.
Milberg P; Hilker E; Ramtin S; Cakir Y; Stypmann J; Engelen MA; Mönnig G; Osada N; Breithardt G; Haverkamp W; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):647-54. PubMed ID: 17388913
[TBL] [Abstract][Full Text] [Related]
16. Antiarrhythmic and cardiac electrophysiological effects of SZV-270, a novel compound with combined Class I/B and Class III effects, in rabbits and dogs.
Varga RS; Hornyik T; Husti Z; Kohajda Z; Krajsovszky G; Nagy N; Jost N; Virág L; Tálosi L; Mátyus P; Varró A; Baczkó I
Can J Physiol Pharmacol; 2021 Jan; 99(1):89-101. PubMed ID: 32970956
[TBL] [Abstract][Full Text] [Related]
17. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
Lu HR; Yan GX; Gallacher DJ
J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiologic features of torsades de pointes: insights from a new isolated rabbit heart model.
Zabel M; Hohnloser SH; Behrens S; Li YG; Woosley RL; Franz MR
J Cardiovasc Electrophysiol; 1997 Oct; 8(10):1148-58. PubMed ID: 9363818
[TBL] [Abstract][Full Text] [Related]
19. Ryanodine-receptor inhibition by dantrolene effectively suppresses ventricular arrhythmias in an ex vivo model of long-QT syndrome.
Frommeyer G; Krawczyk J; Ellermann C; Bögeholz N; Kochhäuser S; Dechering DG; Fehr M; Eckardt L
J Cardiovasc Electrophysiol; 2018 Mar; 29(3):471-476. PubMed ID: 29314443
[TBL] [Abstract][Full Text] [Related]
20. A new mechanism preventing proarrhythmia in chronic heart failure: rapid phase-III repolarization explains the low proarrhythmic potential of amiodarone in contrast to sotalol in a model of pacing-induced heart failure.
Frommeyer G; Milberg P; Witte P; Stypmann J; Koopmann M; Lücke M; Osada N; Breithardt G; Fehr M; Eckardt L
Eur J Heart Fail; 2011 Oct; 13(10):1060-9. PubMed ID: 21873342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
